Low vitamin D levels associated with death from cardiovascular, all causes

Jun 23, 2008

Individuals with lower blood levels of vitamin D appear to have an increased risk of death overall and from cardiovascular causes, according to a report in the June 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

A recent consensus panel estimated that about 50 percent to 60 percent of older individuals in North America and the rest of the world do not have satisfactory vitamin D status, and the situation is similar for younger individuals, according to background information in the article. Blood levels of 25-hydroxyvitamin D, a measure of blood vitamin D levels, lower than 20 to 30 nanograms per milliliter have been associated with falls, fractures, cancer, immune dysfunction, cardiovascular disease and hypertension. These effects are thought to be mediated by the compound 1,25-dihydroxyvitamin D, which is produced by the body and also converted from 25-hydroxyvitamin D.

Harald Dobnig, M.D., of Medical University of Graz, Austria, and colleagues studied 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in 3,258 consecutive patients (average age 62 years) who were scheduled for coronary angiography testing at a single medical center between 1997 and 2000.

During about 7.7 years of follow-up, 737 (22.6 percent) of participants died, including 463 (62.8 percent) who died of cardiovascular causes. Death rates from any cause and from cardiovascular causes were higher among individuals in the lower one-half of 25-hydroxyvitamin D levels and the lowest one-fourth of 1,25-dihydroxyvitamin D levels. These associations remained when the researchers accounted for other factors, including coronary artery disease, physical activity level and co-occurring diseases.

Low 25-hydroxyvitamin D levels also were correlated with markers of inflammation such as C-reactive protein, as well as signs of oxidative (oxygen-related) damage to cells, the authors note.

"Apart from the proved effects that vitamin D has on bone metabolism and neuromuscular function, appropriate serum levels (that may also be higher than in the present investigation) are associated with a decrease in mortality," they conclude. "Although not proved, it seems possible that at least part of this effect may be due to lowering of a risk profile promoting atherosclerosis [narrowing of the arteries] and preventing cardiovascular end points."

Source: JAMA and Archives Journals

Explore further: Hormonal therapy for transsexualism safe and effective

add to favorites email to friend print save as pdf

Related Stories

'Ugly' finding: Unattractive workers suffer more

15 minutes ago

People who are considered unattractive are more likely to be belittled and bullied in the workplace, according to a first-of-its-kind study led by a Michigan State University business scholar.

An environmentally friendly battery made from wood

49 minutes ago

Taking inspiration from trees, scientists have developed a battery made from a sliver of wood coated with tin that shows promise for becoming a tiny, long-lasting, efficient and environmentally friendly energy ...

Sound waves precisely position nanowires

1 hour ago

(Phys.org) —The smaller components become, the more difficult it is to create patterns in an economical and reproducible way, according to an interdisciplinary team of Penn State researchers who, using ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

20 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments : 0

More news stories

Taxing unhealthy food spurs people to buy less

Labeling foods and beverages as less-healthy and taxing them motivates people to make healthier choices, finds a recent study in the American Journal of Preventive Medicine. When faced with a 30 percent tax on ...

Sound waves precisely position nanowires

(Phys.org) —The smaller components become, the more difficult it is to create patterns in an economical and reproducible way, according to an interdisciplinary team of Penn State researchers who, using ...

'Ugly' finding: Unattractive workers suffer more

People who are considered unattractive are more likely to be belittled and bullied in the workplace, according to a first-of-its-kind study led by a Michigan State University business scholar.

Pearly perfection

The mystery of how pearls form into the most perfectly spherical large objects in nature may have an unlikely explanation, scientists are proposing in a new study. It appears in ACS' journal Langmuir, named ...

An environmentally friendly battery made from wood

Taking inspiration from trees, scientists have developed a battery made from a sliver of wood coated with tin that shows promise for becoming a tiny, long-lasting, efficient and environmentally friendly energy ...